Ewing Warriors Assemble

The hospital smelled like antiseptic, a scent that always brought back memories of needles and doctor visits. I fidgeted with the hem of my yellow sundress, the soft cotton fabric standing out against the white walls. My platform sandals clicked on the tiled floor, a small act of defiance in the sterile environment. The charm bracelet on my wrist jingled softly as I walked.

My dad gave my shoulder a reassuring squeeze. "You've got this, Sloane. We're just down the street if you need us."

Pops grinned, his eyes crinkling at the edges. "Remember, you're not just doing this for yourself. You're paving the way for others." He winked, his positivity cutting through the somber mood.

I swallowed hard, feeling the weight of the moment. It wasn't just about me; it was about every child who had faced the dreaded words: "You have cancer."

Taking a deep breath, I pushed open the door to the conference room. The room buzzed with conversation as I entered. All eyes turned towards me, a mix of curiosity and hope.

I saw a girl with raven black hair and a silver ring in her nose. Her eyes were a warm amber color, and her nose was delicate and turned up. She had a playful smile and high cheekbones that made her look young. Next to her was a boy with skin the color of dark chocolate and eyes the color of rich espresso. His nose was broad and strong, and his lips were full and expressive. His cheekbones were high and prominent. On the other side of the room, a girl with a shaved head gave a shy wave. Her eyes were the color of the summer sky and showed quiet strength. Her nose was small and perky, and her lips were thin but expressive. Her cheekbones were sharp and defined. Another boy with sandy brown hair and a gentle face nodded at me. His hazel eyes were kind, and his nose was straight and refined. His lips were full and slightly upturned, and his cheekbones were subtle but well-defined.

I whispered, "Hi, I'm Sloane."

"I'm Samantha," the girl with the nose ring introduced herself, shaking my hand. "And these are Reid, Ally, and Parker."

Meeting them gave me a glimmer of hope. Maybe things wouldn't be so terrible after all.

Dr. Keene, a woman with short, silver hair and hazel eyes, walked to the front of the room. The group fell silent as she greeted us with a warm smile.

"Hello, everyone," Dr. Keene said. Her voice was calm and steady, and it made me feel more at ease. Her nose crinkled slightly as she smiled, and her lips curved gently upwards. She had high cheekbones that gave her a youthful look. "I'm Dr. Keene, and I'm honored to be leading this groundbreaking clinical trial. I know this is a difficult time for all of you, and I want to commend you for your bravery and resilience."

"Before we get started," Dr. Keene continued, motioning to the people behind her, each with a name tag identifying their role: nurse, researcher, counselor. "I'd like to introduce our incredible team."

"These are the dedicated individuals who will be working tirelessly to support you throughout this journey," she explained. Her kind eyes met each person in the room. "They're here to answer your questions, address your concerns, and provide you with the care you need."

Dr. Keene paused, her gaze sweeping across the room. "Now, let's talk about the purpose of this trial," she said. "As you know, Ewing sarcoma is a rare and aggressive form of bone cancer. While there have been advancements in treatment, we believe there's still much more we can do."

Hope flickered in her warm hazel eyes as she spoke. "This trial is designed to evaluate the effectiveness of a promising new therapy. We believe this therapy has the potential to significantly improve outcomes for patients with Ewing sarcoma."

A wave of murmurs rippled through the room, a mix of excitement and apprehension. I glanced at Samantha, Reid, Ally, and Parker, their faces reflecting a similar mix of emotions. We're all in this together, I realized. A band of warriors, fighting for our lives and the lives of countless others.

Dr. Keene's words snapped me back to reality. "This trial will be tough, no doubt about it," she admitted. "But I want you to know that your safety and well-being are our top priorities. We'll be keeping a close eye on you and supporting you every step of the way."

With a reassuring smile, Dr. Keene shifted gears to the technical side of the trial. "Now, let's get into the nitty-gritty of our study protocol," she said.

A screen descended behind her, showing a series of slides outlining the trial's intricate details. "As you can see," she began, "the protocol is quite comprehensive. It covers every aspect of the study, from the exact dosage of the new therapy to the schedule of assessments and follow-up visits."

She walked us through the slides, her voice calm and informative. "We'll be doing a variety of tests throughout the trial, including bloodwork, imaging scans, and physical examinations. These tests will help us track your progress and make sure you're safe," she explained.

Dr. Keene stressed the importance of sticking to the protocol. "It's crucial that you follow the schedule and guidelines in the protocol," she said. "This will help us gather accurate data and ensure the validity of our findings."

To drive the point home, she presented a case study. It told the story of a made-up patient, Aubrianne, who took part in a similar trial. We followed Aubrianne's journey, from her initial diagnosis to her eventual recovery. The case study showed how important it is to follow the protocol and illustrated the potential benefits of the new therapy.

By the end of the presentation, my head was spinning with information. But even though the trial was complex, I felt clear and purposeful. I knew what I had to do, and I was ready to do my part.

A surge of excitement filled the room as we each grabbed a tablet. The screen illuminated, displaying a maze of forms and fields. It seemed a bit overwhelming at first, but Dr. Keene walked us through it with care and expertise.

"These are electronic case report forms, or eCRFs," she clarified. "They will be used to document your progress during the trial. It's crucial that we input every detail accurately and thoroughly."

She demonstrated how to navigate the eCRF, her fingers gliding across the screen. "Each form corresponds to a specific evaluation," she pointed out. "For instance, this form is for your blood test results, and this one is for your imaging scans."

We practiced inputting data into the eCRF, with Dr. Keene providing guidance and corrections when necessary. It felt like learning a new language, but I was determined to excel. I understood the significance of this data, not only for myself but for all those who could benefit from this innovative treatment.

Dr. Keene emphasized the importance of honesty and openness. "It's vital that you document everything truthfully, even if it's something you're not proud of," she emphasized. "We must have a comprehensive understanding of your experience to assess the therapy's effectiveness."

As we continued to practice, I grew more confident. The eCRF, once a complex puzzle, now felt like a valuable tool, a means for me to contribute to a cause greater than myself.

After what seemed like an eternity of being bombarded with information, Dr. Keene finally declared, "Okay everyone, let's take a well-deserved lunch break."

A wave of relief washed over the room as we shut down our tablets. I looked around, hoping to catch the eye of Samantha, Reid, Ally, and Parker. We hadn't had much time to talk during the session, but I was eager to connect with them over lunch.

"Hey," I greeted them as I approached their table. "Mind if I sit with you guys?"

"Of course," Samantha responded, her smile matching the brightness of her amber eyes. "Pull up a chair."

The cafeteria was bustling, but we managed to find a table by the window. I unwrapped my turkey sandwich on whole wheat and took a bite.

"So," Reid began, his espresso eyes twinkling with amusement. "What are your thoughts on everything so far?"

"It's a lot to absorb," Ally confessed, her sky-blue eyes wide with wonder. "But it also feels... hopeful."

"Yeah," Parker chimed in, his soft voice barely audible over the cafeteria noise. "It's like we're part of something really important."

We discussed our aspirations and concerns, our visions for the future. We shared our experiences with diagnoses, treatments, and challenges. As we talked, I felt a sense of unity forming, a connection forged through shared experiences.

Although lunch passed quickly with laughter and storytelling, there was an air of anticipation as we returned to the conference room, feeling united like warriors facing an uncertain future.

A whisper of interest spread across the room as Dr. Keene, sensing our excitement, jumped right into the next subject. "Let's now talk about the investigational product you'll be given in this trial – Lurbinectedin."

Lurbinectedin, I mused to myself. It sounded like it came straight out of a sci-fi book.

Dr. Keene elaborated that Lurbinectedin is a form of chemotherapy that hinders the growth and division of cancer cells. "It's administered intravenously," she added, "which means it will be delivered through a needle inserted into your vein."

A feeling of apprehension washed over me. I had dealt with my fair share of IVs in the past, and the idea of more needles wasn't exactly thrilling. However, I reminded myself of what was on the line. This drug, Lurbinectedin, could be my saving grace.

Dr. Keene proceeded to outline the possible side effects of the drug. Nausea, fatigue, hair loss – the list was extensive and intimidating. Nevertheless, she reassured us that the medical team would be closely monitoring us and providing supportive care throughout the trial.

"It's crucial that you report any side effects you encounter," she stressed. "Even if they seem minor, it's essential for us to document them. This data will help us comprehend the drug's safety profile and ensure your well-being."

She then guided us through the process of reporting adverse events. "If you notice any unusual symptoms, regardless of how insignificant they may seem, please inform us right away. You can reach out to your study nurse, or you can directly report it through the eCRF."

As I absorbed Dr. Keene's guidance, a sense of duty settled within me. I wasn't just a participant in this trial, but also a data gatherer, a crucial link in the chain of scientific exploration. I understood that my accurate and prompt reporting of any side effects could impact the lives of numerous individuals.

The room was filled with a mix of excitement and nervousness as Dr. Keene changed the topic. "Let's now focus on the practical side of your involvement in the trial."

We were split into smaller groups, each guided by a member of the research team. My group, which included me, Samantha, Reid, Ally, and Parker, gathered around a friendly young woman named Nurse Charlotte.

"We're going to practice some role-play scenarios," Nurse Charlotte explained. "These will help you prepare for your study visits and communicate effectively with the medical team."

The first scenario was about getting informed consent. Samantha volunteered to be the patient, while Nurse Charlotte played the doctor. They carefully went through the process, discussing the trial's risks and benefits, answering questions, and making sure Samantha understood everything before signing the consent form.

After that, we practiced scenarios for study visits, from checking in at the front desk to receiving the Lurbinectedin infusion. We were taught how to report any side effects or concerns, and how to ask questions about our treatment plan.

The last scenario focused on emergency procedures. Nurse Charlotte explained the steps to take in case of a medical emergency, from contacting the study team to seeking immediate medical help. We talked about the importance of staying calm and following instructions, even in a crisis.

After finishing the role-play exercises, I felt more confident. I now had a better idea of what was expected of me, and I felt ready to handle any situation that might come up.

Dr. Keene, who had been watching our practice, spoke to the group again. "Remember," she said, "we're here to help you every step of the way. If you have any questions or concerns, don't hesitate to ask. We're all in this together."

Dr. Keene welcomed questions from the audience, causing a murmur of whispers and shuffling papers to fill the room. Hands hesitantly went up, each question reflecting the mix of emotions and uncertainties we were all experiencing.

"What if the side effects become too much to handle?" a participant inquired, their voice quivering slightly.

Dr. Keene nodded in understanding. "That's a valid concern," she replied. "We will closely monitor you during the trial and have various support measures in place to help manage any side effects. If they become too severe, we can adjust your treatment plan or remove you from the trial if needed. Your well-being is our main priority."

Another participant raised their hand, looking worried. "What happens once the trial ends?"

Dr. Keene smiled reassuringly. "That's an excellent question," she answered. "If the trial is successful, we aim to offer this therapy to all Ewing sarcoma patients. Even if you don't directly benefit from the trial, your participation will contribute to future treatments and enhance outcomes for many others."

Questions kept coming, covering topics like insurance and the emotional impact of the trial. Dr. Keene and her team patiently and compassionately addressed each one, showing their unwavering commitment to our well-being.

As the session wrapped up, Dr. Keene shared some words of encouragement. "We're embarking on this journey together," she stated. "It won't be easy, but I have faith in each of you. You're strong, you're resilient, and you can make a difference."

She paused, looking around the room, making eye contact with each of us. "Remember, you're not alone. We're here to support you every step of the way. You have a team of dedicated professionals and each other. Together, we can confront this challenge head-on."

The room was filled with a sense of togetherness as we clapped for Dr. Keene and her team. Packing up my things, I felt a jumble of emotions – fear, doubt, but also optimism. I knew the journey ahead wouldn't be easy, but I also knew I had a support system. My family, new friends, and a group of professionals were all in my corner. With their help, I was prepared to tackle whatever challenges lay ahead.

The rest of the orientation flew by with paperwork, tests, and meetings with Dr. Keene and her team. By the end of the day, I was drained but oddly excited. I had taken the first step towards a new beginning, one that could bring healing, hope, and a brighter tomorrow.

As we left the conference room, Samantha looked at me with her bright amber eyes. "Hey Sloane, should we take a group photo? To remember the start of this crazy adventure."

"Sure, great idea," I replied, grinning.

We gathered together, linking arms and smiling. Reid made a funny face, making us all laugh. Parker took a picture with his phone.

"Send it to me!" Ally said, her excited sky-blue eyes shining. "Let's also create a group chat. We need to stay connected."

In just a few minutes, a new group chat was created, named "Ewing Warriors." The first message appeared on my screen: a photo of our happy faces, a symbol of our shared struggle and unwavering hope.

"To new beginnings," Samantha typed, followed by a series of emojis.

"To beating cancer," Reid added.

"To friendship," Ally chimed in.

"To hope," Parker wrote.

I paused, my fingers hovering over the keyboard. What did I want to say? What words could capture the whirlwind of emotions swirling within me?

Finally, I typed a single word: "To us."

As I hit send, a wave of warmth washed over me. I was no longer alone in this fight. I had my fellow warriors, my partners in crime, my friends. Together, we would face the unknown, hand in hand, heart to heart. We would fight, we would laugh, we would cry, we would hope. And no matter what the future held, we would never give up.